# Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

> **NCT06808516** · PHASE2 · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 42 (estimated)

## Conditions studied

- Arginine Vasopressin Deficiency
- Central Diabetes Insipidus
- Oxytocin Deficiency

## Interventions

- **DRUG:** Oxytocin nasal spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06808516
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06808516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06808516, "Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06808516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*